282 related articles for article (PubMed ID: 21450813)
1. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.
Frecha C; Lévy C; Costa C; Nègre D; Amirache F; Buckland R; Russell SJ; Cosset FL; Verhoeyen E
J Virol; 2011 Jun; 85(12):5975-85. PubMed ID: 21450813
[TBL] [Abstract][Full Text] [Related]
2. Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.
Frecha C; Costa C; Nègre D; Gauthier E; Russell SJ; Cosset FL; Verhoeyen E
Blood; 2008 Dec; 112(13):4843-52. PubMed ID: 18812471
[TBL] [Abstract][Full Text] [Related]
3. Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM.
Zhou Q; Schneider IC; Gallet M; Kneissl S; Buchholz CJ
Virology; 2011 May; 413(2):149-52. PubMed ID: 21470651
[TBL] [Abstract][Full Text] [Related]
4. Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells.
Humbert JM; Frecha C; Amirache Bouafia F; N'Guyen TH; Boni S; Cosset FL; Verhoeyen E; Halary F
J Virol; 2012 May; 86(9):5192-203. PubMed ID: 22345444
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.
Lévy C; Amirache F; Costa C; Frecha C; Muller CP; Kweder H; Buckland R; Cosset FL; Verhoeyen E
Mol Ther; 2012 Sep; 20(9):1699-712. PubMed ID: 22617109
[TBL] [Abstract][Full Text] [Related]
6. Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins.
Schoenhals M; Frecha C; Bruyer A; Caraux A; Veyrune JL; Jourdan M; Moreaux J; Cosset FL; Verhoeyen E; Klein B
Leukemia; 2012 Jul; 26(7):1663-70. PubMed ID: 22318450
[TBL] [Abstract][Full Text] [Related]
7. Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors.
Frecha C; Costa C; Lévy C; Nègre D; Russell SJ; Maisner A; Salles G; Peng KW; Cosset FL; Verhoeyen E
Blood; 2009 Oct; 114(15):3173-80. PubMed ID: 19667401
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
[TBL] [Abstract][Full Text] [Related]
9. The measles virus hemagglutinin β-propeller head β4-β5 hydrophobic groove governs functional interactions with nectin-4 and CD46 but not those with the signaling lymphocytic activation molecule.
Mateo M; Navaratnarajah CK; Syed S; Cattaneo R
J Virol; 2013 Aug; 87(16):9208-16. PubMed ID: 23760251
[TBL] [Abstract][Full Text] [Related]
10. Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity.
Funke S; Schneider IC; Glaser S; Mühlebach MD; Moritz T; Cattaneo R; Cichutek K; Buchholz CJ
Gene Ther; 2009 May; 16(5):700-5. PubMed ID: 19212424
[TBL] [Abstract][Full Text] [Related]
11. Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.
Vongpunsawad S; Oezgun N; Braun W; Cattaneo R
J Virol; 2004 Jan; 78(1):302-13. PubMed ID: 14671112
[TBL] [Abstract][Full Text] [Related]
12. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein.
Hashimoto K; Ono N; Tatsuo H; Minagawa H; Takeda M; Takeuchi K; Yanagi Y
J Virol; 2002 Jul; 76(13):6743-9. PubMed ID: 12050387
[TBL] [Abstract][Full Text] [Related]
13. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
Kneissl S; Abel T; Rasbach A; Brynza J; Schneider-Schaulies J; Buchholz CJ
PLoS One; 2012; 7(10):e46667. PubMed ID: 23071609
[TBL] [Abstract][Full Text] [Related]
14. Recombinant wild-type measles virus containing a single N481Y substitution in its haemagglutinin cannot use receptor CD46 as efficiently as that having the haemagglutinin of the Edmonston laboratory strain.
Seki F; Takeda M; Minagawa H; Yanagi Y
J Gen Virol; 2006 Jun; 87(Pt 6):1643-1648. PubMed ID: 16690929
[TBL] [Abstract][Full Text] [Related]
15. Structure of the measles virus hemagglutinin bound to the CD46 receptor.
Santiago C; Celma ML; Stehle T; Casasnovas JM
Nat Struct Mol Biol; 2010 Jan; 17(1):124-9. PubMed ID: 20010840
[TBL] [Abstract][Full Text] [Related]
16. Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein.
Santiago C; Björling E; Stehle T; Casasnovas JM
J Biol Chem; 2002 Aug; 277(35):32294-301. PubMed ID: 12065582
[TBL] [Abstract][Full Text] [Related]
17. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition.
Erlenhoefer C; Wurzer WJ; Löffler S; Schneider-Schaulies S; ter Meulen V; Schneider-Schaulies J
J Virol; 2001 May; 75(10):4499-505. PubMed ID: 11312320
[TBL] [Abstract][Full Text] [Related]
18. Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis.
Shingai M; Ayata M; Ishida H; Matsunaga I; Katayama Y; Seya T; Tatsuo H; Yanagi Y; Ogura H
J Gen Virol; 2003 Aug; 84(Pt 8):2133-2143. PubMed ID: 12867645
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of measles virus entry and dissemination through different receptors.
Schneider U; von Messling V; Devaux P; Cattaneo R
J Virol; 2002 Aug; 76(15):7460-7. PubMed ID: 12097558
[TBL] [Abstract][Full Text] [Related]
20. CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes.
Kneissl S; Zhou Q; Schwenkert M; Cosset FL; Verhoeyen E; Buchholz CJ
PLoS One; 2013; 8(11):e79047. PubMed ID: 24244415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
